September 23, 2014 12:34 PM ET

Biotechnology

Company Overview of Idenix Pharmaceuticals Inc.

Executive Profile

Eugene R. Schiff M.D., F.A.C.P., F.R.C.P., M.A.C.G.

Member of the Scientific Advisory Board, Gilead Sciences Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 5 different industries.

See Board Relationships
----

Background

Dr. Eugene R. Schiff, M.D., FACP, FRCP, MACG is Professor of Medicine, Chief of the Division of Hepatology, and Director of the Center for Liver Diseases at the University of Miami School of Medicine in Miami, Florida. Dr. Schiff served as Director of Scientific and Development Advisory Board at Maxim Pharmaceuticals, Inc. since February 6, 2003. He serves as a Member of the Hepatitis Scientific Advisory Board of Idenix Pharmaceuticals Inc. He serves as a Member of Scientific ...

Corporate Headquarters

320 Bent Street
Cambridge, Massachusetts 02141

United States

Phone: 617-995-9800
Fax: 617-995-9801

Board Members Memberships

There is no Board Members Memberships data available.

Education

Master's Degree
American College of Gastroenterology

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Idenix Pharmaceuticals Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.